128th ENMC International Workshop on 'Preclinical optimization and Phase I/II Clinical Trials Using Antisense Oligonucleotides in Duchenne Muscular Dystrophy' 22-24 October 2004, Naarden, The Netherlands

Neuromuscul Disord. 2005 Jun;15(6):450-7. doi: 10.1016/j.nmd.2005.02.007. Epub 2005 Apr 18.
No abstract available

Publication types

  • Consensus Development Conference
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Clinical Trials, Phase I as Topic*
  • Clinical Trials, Phase II as Topic*
  • Genetic Therapy / methods*
  • Humans
  • Muscular Dystrophy, Duchenne / therapy*
  • Oligonucleotides, Antisense / therapeutic use*

Substances

  • Oligonucleotides, Antisense